Cargando…
Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer
Triple-negative breast cancer (TNBC), which is the most malignant subtype of breast cancer (BC), accounts for 10%–20% of all BC cases. TNBC, which occurs more frequently in young women, is characterized by high rates of cell proliferation and metastasis and poor prognosis. Chemotherapy is the primar...
Autores principales: | Tian, Tian, Zhao, Yangzhi, Zheng, Jingying, Jin, Shunzi, Liu, Zhongshan, Wang, Tiejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411013/ https://www.ncbi.nlm.nih.gov/pubmed/34513294 http://dx.doi.org/10.1016/j.omtn.2021.06.017 |
Ejemplares similares
-
Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era
por: Li, Huanhuan, et al.
Publicado: (2023) -
The Role of Exosomes in the Female Reproductive System and Breast Cancers
por: Bai, Yuqi, et al.
Publicado: (2020) -
Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022) -
Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers
por: Liu, Yiduo, et al.
Publicado: (2021) -
Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)